Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $22.59, but opened at $21.82. Daiichi Sankyo shares last traded at $21.82, with a volume of 74,478 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research lowered Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Daiichi Sankyo currently has a consensus rating of “Moderate Buy”.
Get Our Latest Stock Report on DSNKY
Daiichi Sankyo Stock Performance
Daiichi Sankyo Company Profile
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Stories
- Five stocks we like better than Daiichi Sankyo
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
- A month before the crash
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
